Pharmacogenomics: Time to rethink its role in precision medicine

J. A. Willis; E. Vilar

doi:10.1093/annonc/mdx780

Pharmacogenomics: Time to rethink its role in precision medicine

Clinical Cancer Prevention

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	293-295
Number of pages	3
Journal	Annals of Oncology
Volume	29
Issue number	2
DOIs	https://doi.org/10.1093/annonc/mdx780
State	Published - Feb 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdx780

Cite this

@article{e21ebc5be5dc4b7c9e599991827d8643,

title = "Pharmacogenomics: Time to rethink its role in precision medicine",

author = "Willis, \{J. A.\} and E. Vilar",

year = "2018",

month = feb,

day = "1",

doi = "10.1093/annonc/mdx780",

language = "English (US)",

volume = "29",

pages = "293--295",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

number = "2",

}

TY - JOUR

T1 - Pharmacogenomics

T2 - Time to rethink its role in precision medicine

AU - Willis, J. A.

AU - Vilar, E.

PY - 2018/2/1

Y1 - 2018/2/1

UR - https://www.scopus.com/pages/publications/85042566061

UR - https://www.scopus.com/pages/publications/85042566061#tab=citedBy

U2 - 10.1093/annonc/mdx780

DO - 10.1093/annonc/mdx780

M3 - Editorial

C2 - 29236957

AN - SCOPUS:85042566061

SN - 0923-7534

VL - 29

SP - 293

EP - 295

JO - Annals of Oncology

JF - Annals of Oncology

IS - 2

ER -

Pharmacogenomics: Time to rethink its role in precision medicine

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this